Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Innvative approaches to identification of metabolic Targets for antimicrobials

Project description

Novel targets to reverse antimicrobial resistance

Antimicrobial resistance is a growing medical challenge, hampering the effectiveness of existing drugs and threatening the lives of patients. Therefore, there is a pressing need for compounds that re-sensitise drug-resistant bacteria to existing antimicrobials. To address this problem, the EU-funded INNOTARGETS project will train early-stage researchers in the identification of novel metabolic drug targets in pathogenic bacteria. The project comes as a collaboration between academia and industry and will guide researchers to use innovative approaches to achieve their scientific goals. Research activities will focus on metabolic enzymes necessary or redundant for infection as well as others responsible for antimicrobial resistance. The work will create new research opportunities for tackling antimicrobial resistance.

Objective

Antimicrobial resistance (AMR) is a challenge to human health and health-systems, and we need novel antimicrobials or drugs that can re-sensitize multi drug resistant (MDR) bacteria to existing antimicrobials. Metabolic enzymes have largely been ignored in the search for antimicrobial targets, and they are an untapped resource. The aim of INNOTARGETS is to train ESRs in highly innovative approaches to identify metabolic drug targets in pathogenic bacteria. The training will deliver ESRs that can become creative, future research team leaders within industry or academia. The network joins 7 academic and 3 non-academic organisations, including two antibiotic discovery companies. The training is multi-disciplinary and trans-sectoral and provides 432 person-months of training to 12 ESRs. The types of targets foreseen are: 1) Metabolic enzymes that are essential for infection, Such enzymes will be identified by use of transposon libraries 2) Redundant enzymes, which can be blocked in parallel. Relevant pairs of enzymes will be identified by use of metabolic models, and a search for bioactive molecules, with affinity for more than one target will be carried out using a novel screening platform. 3) Metabolic enzymes which are essential for expression of resistance mechanisms or spread of resistance plasmids in MDR bacteria. Putative targets for all three types of reactions will be validated using cell culture and animal models.

INNOTARGETS will establish a joint training syllabus designed to widen the career prospects of the ESRs and to optimize their professional competences. It includes training through research, including secondments, network wide training courses and summer schools, self-directed learning, workshops and training through interaction with external partners and visiting scientists.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-ITN-2020

See all projects funded under this call

Coordinator

KOBENHAVNS UNIVERSITET
Net EU contribution
€ 884 301,50
Address
NORREGADE 10
1165 KOBENHAVN
Denmark
Region
Danmark Hovedstaden Byen København
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 884 301,50

Participants (8)